RE: "CURRENT CHALLENGES AND NEW OPPORTUNITIES FOR GENE-ENVIRONMENT INTERACTION STUDIES OF COMPLEX DISEASES"

Affiliations

¹ Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
² Office of the Director, Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, MD.

Comment

Danielle Mercatante Carrick et al. Am J Epidemiol. 2018.

. 2018 May 1;187(5):1128-1129.

doi: 10.1093/aje/kwy037.

¹ Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD.
² Office of the Director, Center for Strategic Scientific Initiatives, National Cancer Institute, Bethesda, MD.

No abstract available

Comment on

Current Challenges and New Opportunities for Gene-Environment Interaction Studies of Complex Diseases.
McAllister K, Mechanic LE, Amos C, Aschard H, Blair IA, Chatterjee N, Conti D, Gauderman WJ, Hsu L, Hutter CM, Jankowska MM, Kerr J, Kraft P, Montgomery SB, Mukherjee B, Papanicolaou GJ, Patel CJ, Ritchie MD, Ritz BR, Thomas DC, Wei P, Witte JS. McAllister K, et al. Am J Epidemiol. 2017 Oct 1;186(7):753-761. doi: 10.1093/aje/kwx227. Am J Epidemiol. 2017. PMID: 28978193 Free PMC article.

1. McAllister K, Mechanic LE, Amos C, et al. . Current challenges and new opportunities for gene-environment interaction studies of complex diseases. Am J Epidemiol. 2017;186(7):753–761. - PMC - PubMed
1. Center for Strategic Scientific Initiatives, National Cancer Institute Innovative Molecular Analysis Technologies. https://imat.cancer.gov/. Accessed January 25, 2018.
1. National Cancer Institute Department of Health and Human Services. Part 1. Overview information. Revisions for incorporation of novel NCI-supported technology to accelerate cancer research (R01 clinical trial optional). RFA-CA-18-006. https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-006.html. Published December 4, 2017. Accessed January 25, 2018.
1. National Cancer Institute Department of Health and Human Services. Part 1. Overview information. Revisions for incorporation of novel NCI-supported technology to accelerate cancer research (U01 clinical trial optional). RFA-CA-18-007. https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-007.html. Published December 4, 2017. Accessed January 25, 2018.
1. National Cancer Institute Department of Health and Human Services. Part 1. Overview information. Revisions for incorporation of novel NCI-supported technology to accelerate cancer research (U54 clinical trial optional). RFA-CA-18-008. https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-18-008.html. Published December 4, 2017. Accessed January 25, 2018.